154 related articles for article (PubMed ID: 21425940)
1. Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes.
Song YK; Hyun SY; Kim HT; Kim CK; Oh JM
J Microencapsul; 2011; 28(3):151-8. PubMed ID: 21425940
[TBL] [Abstract][Full Text] [Related]
2. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes.
Song YK; Kim CK
Biomaterials; 2006 Jan; 27(2):271-80. PubMed ID: 16039711
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation.
Lanke SS; Kolli CS; Strom JG; Banga AK
Int J Pharm; 2009 Jan; 365(1-2):26-33. PubMed ID: 18801420
[TBL] [Abstract][Full Text] [Related]
4. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
5. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes.
Shen LN; Zhang YT; Wang Q; Xu L; Feng NP
Int J Pharm; 2014 Jan; 460(1-2):280-8. PubMed ID: 24269286
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
7. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evaluation of an oral tablet form of low-molecular-weight heparin and deoxycholic acid conjugate as a novel oral anticoagulant.
Park JW; Jeon OC; Kim SK; Al-Hilal TA; Lim KM; Moon HT; Kim CY; Byun Y
Thromb Haemost; 2011 Jun; 105(6):1060-71. PubMed ID: 21437357
[TBL] [Abstract][Full Text] [Related]
10. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates.
Kim SK; Lee EH; Vaishali B; Lee S; Lee YK; Kim CY; Moon HT; Byun Y
J Control Release; 2005 Jun; 105(1-2):32-42. PubMed ID: 15925422
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
[TBL] [Abstract][Full Text] [Related]
13. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
[TBL] [Abstract][Full Text] [Related]
14. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes.
Dubey V; Mishra D; Nahar M; Jain V; Jain NK
Nanomedicine; 2010 Aug; 6(4):590-6. PubMed ID: 20093197
[TBL] [Abstract][Full Text] [Related]
15. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
Pharmazie; 2007 Feb; 62(2):133-7. PubMed ID: 17341034
[TBL] [Abstract][Full Text] [Related]
16. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
[TBL] [Abstract][Full Text] [Related]
17. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.
Hoffart V; Lamprecht A; Maincent P; Lecompte T; Vigneron C; Ubrich N
J Control Release; 2006 Jun; 113(1):38-42. PubMed ID: 16697485
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic indications of low molecular weight heparins].
Samama MM; Michaut-Paterno F
Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941
[TBL] [Abstract][Full Text] [Related]
19. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir.
Zhou Y; Wei YH; Zhang GQ; Wu XA
Arch Pharm Res; 2010 Apr; 33(4):567-74. PubMed ID: 20422366
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
Grimaudo V; Omri A; Kruithof EK; Hauert J; Bachmann F
Thromb Haemost; 1988 Jun; 59(3):388-91. PubMed ID: 2847348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
